Pharmacological profile of ritanserin: A very specific central serotonin S2-antagonist
β Scribed by Dr. Frans Awouters; Carlos J. E. Niemegeers; Anton A. H. P. Megens; Theo F. Meert; Paul A. J. Janssen
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 801 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Serotonergic mechanisms have recently been implicated in the pathogenesis of portal hypertension; this suggests that blockade of serotonin S2 receptors may be a new approach for the pharmacological therapy of portal hypertension. This study was aimed at investigating the effects of ritanserin, a sel
This study investigated the short-term effects of ritanserin, a selective and specific S2-serotonergic antagonist, in an experimental model of cirrhosis and intrahepatic portal hypertension caused by long-term bile duct ligation and division and in normal control rats. The rats subjected to bile duc